汇宇制药: 关于超募资金投资项目结项的公告

Core Points - Sichuan Huiyu Pharmaceutical Co., Ltd. has completed the investment project "High-end Green Pharmaceutical Industry Extension Project" using the raised funds and is now proposing to conclude this project [1][4] - The total amount raised from the public offering was 2,472.132 million RMB, with a net amount after deducting issuance costs [1] - The company has utilized 1,907.315 million RMB for projects related to its main business, with an additional 453.3598 million RMB from over-raised funds [2][4] Fundraising and Investment Project Details - The company issued 63,600,000 shares at a price of 38.87 RMB per share, leading to a total fundraising amount of 2,472.132 million RMB [1] - The total investment amount for the main business-related projects was 1,907.315 million RMB, while the total amount of over-raised funds was 453.3598 million RMB [2] - As of the announcement date, the remaining unused amount of over-raised funds was 44.46 RMB [2] Project Completion and Financial Summary - The "High-end Green Pharmaceutical Industry Extension Project" has completed construction, with some production lines already in trial production, meeting the conditions for project conclusion [4] - The total investment for the project was 315.61 million RMB, with 288.61 million RMB already invested and a remaining balance of 17.60753 million RMB after accounting for interest income [4] - The supervisory board has approved the conclusion of the project, confirming that it aligns with the interests of the company and its shareholders [4]